Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joshua J. Bies
Observed names:
Joshua Bies,
Joshua J Bies
Institutions:
Nebraska Medical Center,
University of Nebraska Medical Center
Observed institutions:
University of North Carolina at Chapel Hill,
University of Nebraska–Lincoln,
California Institute of Technology,
Nebraska Medical Center,
Children's Hospital & Medical Center,
University of Nebraska Medical Center
show all 6
OpenAlex ID:
A5039246270
Cadmium-mediated rescue from ER-associated degradation induces expression of its exporter
2009
·
David J. Adle
, Wenzhong Wei
, et al.
·
Proceedings of the National Academy of Sciences
·
53
Outcomes of pediatric patients with therapy-related myeloid neoplasms
2021
·
Akshay Sharma
, Sujuan Huang
, et al.
·
Bone Marrow Transplantation
·
11
Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment
2025
·
Kristin A. Shimano
, Amanda B. Grimes
, et al.
·
JAMA
·
7
Reduced Intensity Vs Myeloablative Conditioning Regimen for Pediatric Therapy-Related Myelodysplastic Syndrome/Acute Myeloid Leukemia
2019
·
Akshay Sharma
, Russell J. Brooke
, et al.
·
Transplantation and Cellular Therapy
·
2
Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United States
2025
·
Bryan A. Sisk
, Whitney Eng
, et al.
·
Pediatric Blood & Cancer
·
1
Efficacy Findings in a Phase 3, Randomized Trial of Eltrombopag Vs. Standard First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia in Children
2024
·
Kristin A. Shimano
, Amanda B. Grimes
, et al.
·
Blood
·
1
Use of plerixafor for short‐term management of leukopenia in a pediatric patient with WHIM syndrome
2024
·
Beatriz Caceres‐Nazario
, Kimberly A. Kasow
, et al.
·
Pediatric Blood & Cancer
·
1
PDF
End-of-study results from the ICON3 pines trial, a phase 3, randomized trial of eltrombopag vs. standard first-line treatment for newly diagnosed immune thrombocytopenia in children
2025
·
Kristin Shimano
, Amanda Grimes
, et al.
·
Blood
PDF
A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children: Trial in Progress Update
2023
·
Amanda B. Grimes
, Rachael F. Grace
, et al.
·
Blood
PDF
Successful Allogeneic HCT for W.H.I.M. Unexpectedly Complicated By Hypersensitivity Pneumonitis
2019
·
Joshua J. Bies
, Timothy J. Vece
, et al.
·
Transplantation and Cellular Therapy
Show more works
View as search
Works count:
10
Citation count:
76
H-index:
3
I10-index:
2
Year
Topic
Type